Ulisse Biomed
UBM | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005451213 (+1 more)
- LEI:
- 815600F9C180B297BE35
- Country:
- Italy
- Address:
- VIA AQUILEIA, 17, 33100 UDINE
- Website:
- https://www.ulissebiomed.com/en
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Ulisse BioMed is an Italian healthcare biotech company Founded in 2015, Ulisse BioMed is an Italian healthcare biotech company with corporate offices in Udine, Italy and with R&D and Manufacturing labs in Trieste, Italy. Ulisse BioMed is creating novel, innovative and transformative diagnostic platforms and products. The Company mission and purpose for the science, technologies and products is to create new diagnostic modalities and care models in settings never thought possible throughout the world.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Ulisse Biomed.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-31 19:58 |
Share Issue/Capital Change
SIGNED AN INVESTMENT AGREEMENT WITH U.S. INVESTOR GLOBAL CORPORATE FINANCE
|
English | 323.4 KB | |
| 2025-07-31 19:37 |
Share Issue/Capital Change
SOTTOSCRITTO UN ACCORDO DI INVESTIMENTO CON L’INVESTITORE STATUNITENSE GLOBAL C…
|
Italian | 540.4 KB | |
| 2025-07-23 18:37 |
Share Issue/Capital Change
COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE
|
Italian | 255.4 KB | |
| 2025-06-30 17:38 |
Share Issue/Capital Change
“WARRANT ULISSE BIOMED S.P.A. 2021-2026”: RISULTATI DEL SETTIMO PERIODO DI ESER…
|
Italian | 241.8 KB | |
| 2025-05-30 12:21 |
Share Issue/Capital Change
APERTURA DEL SETTIMO PERIODO DI ESERCIZIO DEI “WARRANT ULISSE BIOMED S.P.A. 202…
|
Italian | 188.9 KB | |
| 2025-05-12 12:02 |
Report Publication Announcement
WEBSIM INIZIA LA COPERTURA DEL TITOLO UBM
|
Italian | 181.7 KB | |
| 2025-04-28 16:36 |
Pre-Annual General Meeting Information
RINVIO ASSEMBLEA ORDINARIA E STRAORDINARIA IN SECONDA CONVOCAZIONE
|
Italian | 181.0 KB | |
| 2025-04-12 14:07 |
Pre-Annual General Meeting Information
CONVOCAZIONE DELL’ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI E DEPOSIT…
|
Italian | 203.8 KB | |
| 2025-03-28 21:22 |
Annual / Quarterly Financial Statement
IL CONSIGLIO DI AMMINISTRAZIONE DI ULISSE BIOMED APPROVA IL PROGETTO DI BILANCI…
|
Italian | 488.4 KB | |
| 2025-03-12 06:50 |
Regulatory News Service
AVVIO DELLA SECONDA FASE DEL PROGETTO DI SVILUPPO PER LA LOTTA CONTRO LA MALARIA
|
Italian | 185.7 KB | |
| 2025-02-14 17:43 |
Share Issue/Capital Change
COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE
|
Italian | 250.9 KB | |
| 2025-01-29 17:52 |
Report Publication Announcement
CALENDARIO EVENTI SOCIETARI 2025
|
Italian | 189.2 KB | |
| 2024-12-30 18:28 |
Major Shareholding Notification
COMUNICAZIONE CAMBIAMENTO SOSTANZIALE DEGLI AZIONISTI RILEVANTI (ART.17 REGOLAM…
|
Italian | 229.0 KB | |
| 2024-12-30 18:10 |
Share Issue/Capital Change
INTERAMENTE SOTTOSCRITTO L’AUMENTO DI CAPITALE SOCIALE PER UN AMMONTARE COMPLES…
|
Italian | 210.4 KB | |
| 2024-12-27 20:59 |
Share Issue/Capital Change
IL CONSIGLIO DI AMMINISTRAZIONE ESERCITA LA DELEGA AD AUMENTARE IL CAPITALE SOC…
|
Italian | 274.6 KB |
Automate Your Workflow. Get a real-time feed of all Ulisse Biomed filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Ulisse Biomed via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Double Bond Pharmaceutical International AB | Sweden | DBP B | |
|
Eckert & Ziegler Strahlen- und Medizintechnik AG | Germany | EUZ | |
|
Ectin Research AB | Sweden | ECTIN B | |
|
Elanix Biotechnologies AG | Germany | ELN | |
|
Elbit Meditec-M Ltd. | Israel | EMTC-M | |
|
Elicera Therapeutics AB | Sweden | ELIC | |
|
Elron Ventures Ltd. | Israel | ELRN | |
|
Enlivex Therapeutics Ltd. | Israel | ENLV | |
|
ERYTECH Pharma S.A. | France | ERYP | |
|
Eurobio Scientific | France | ALERS |